---
figid: PMC8468947__pharmaceuticals-14-00868-g001
figtitle: 'Lactoferrin and Its Potential Impact for the Relief of Pain: A Preclinical
  Approach'
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Camelus dromedarius
- Homo sapiens
- Escherichia coli LF82
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Bos taurus
- Camelus dromedarius
- Danio rerio
pmcid: PMC8468947
filename: pharmaceuticals-14-00868-g001.jpg
figlink: /pmc/articles/PMC8468947/figure/pharmaceuticals-14-00868-f001/
number: F1
caption: Presumable effect of bovine lactoferrin (bLf) on the damage-associated molecular
  pattern (DAMP)–Toll-like receptor 4 (TLR4)–TRAF6–nuclear factor κB (NFκB) signaling
  pathway. Tissue damage leads to host-derived endogenous DAMPs. The latter activate
  MyD88-dependent pathway via TLR4 signaling, thus initiating the transcription of
  cytokines that produce nociception and inflammation. Pre-treatment with bLf prevents
  inflammation by avoiding the activation of TRAF6, IKK, p38, and p65. This figure
  was created with Biorender.com (accessed on 25 August 2021).
papertitle: 'Lactoferrin and Its Potential Impact for the Relief of Pain: A Preclinical
  Approach.'
reftext: Beatriz Godínez-Chaparro, et al. Pharmaceuticals (Basel). 2021 Sep;14(9):868.
year: '2021'
doi: 10.3390/ph14090868
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI
keywords: lactoferrin | pain | opioids | NO | NFκB
automl_pathway: 0.9634991
figid_alias: PMC8468947__F1
figtype: Figure
redirect_from: /figures/PMC8468947__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8468947__pharmaceuticals-14-00868-g001.html
  '@type': Dataset
  description: Presumable effect of bovine lactoferrin (bLf) on the damage-associated
    molecular pattern (DAMP)–Toll-like receptor 4 (TLR4)–TRAF6–nuclear factor κB (NFκB)
    signaling pathway. Tissue damage leads to host-derived endogenous DAMPs. The latter
    activate MyD88-dependent pathway via TLR4 signaling, thus initiating the transcription
    of cytokines that produce nociception and inflammation. Pre-treatment with bLf
    prevents inflammation by avoiding the activation of TRAF6, IKK, p38, and p65.
    This figure was created with Biorender.com (accessed on 25 August 2021).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tlr4
  - Chuk
  - Ikbkb
  - Myd88
  - Irak1
  - Irak4
  - Traf6
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Nfkb1
  - Jun
  - Lrp1
  - Mvp
  - Txlng
  - Tnf
  - Il1
  - Il6
  - Il18
  - TLR4
  - CHUK
  - IKBKB
  - MYD88
  - IRAK1
  - IRAK4
  - TRAF6
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - TNF
  - IL1A
  - IL1B
  - IL6
  - IL18
  - Rela
  - Ptpra
  - myd88
  - irak1
  - irak4
  - traf6
  - mapk14a
  - blf
  - cby1
  - tnfa
  - tnfb
  - il6
---
